DETERMINANTS AND MECHANISMS OF MEASLES PATHOGENESIS

麻疹发病的决定因素和机制

基本信息

  • 批准号:
    2659106
  • 负责人:
  • 金额:
    $ 17.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-30 至 1999-09-29
  • 项目状态:
    已结题

项目摘要

The long-term objective is to gain knowledge of the rival and host determinants contributing to measles and vaccine-induced immunosuppression. Measles virus (MV) infects monocytes/macrophages and induces suppression of interleukin-12 production important for cellular immunity. We hypothesize that immunosuppression is triggered by interaction between the MV hemagglutinin (H) protein and human cell receptor CD46 which sequesters cellular factors important for macrophage activation. The H proteins of laboratory and vaccine MV strains induce CD46 downregulation from the infected cell surface, whereas the wild-type MV H proteins do not cause CD46 downregulation. We hypothesize that this difference allows wild-type MV to interact continuously with CD46 to cause prolonged immunosuppression. In support of these hypotheses, we have identified a tyrosine-containing sequence in the CD46 cytoplasmic domain essential for CD46 downregulation. This CD46 sequence resembles known "tyrosine activation motifs" recognized by Src family kinases. Mitogen treatment of macrophages induces a transient increase in cellular kinase activities which associate with the CD46 cytoplasmic domain and cause tyrosine phosphorylation in vitro. Multiple CD46-associated proteins also become phosphorylated. The roles of the MV H protein, CD46, and macrophage activation factors in measles/vaccine-induced immunosuppression must be clearly understood in order to design better vaccines or therapeutics against measles. Our Specific Aims are: 1. Characterize the eCD46 sequences which interact with mitogen-inducible macrophage kinases and identify those kinases. 2. Determine the roles of the CD46 sequences and macrophage kinases in MV-induced immunosuppression. 3. Define the amino acid residues in the MV H proteins of wild-type versus laboratory-adapted MV responsible for differential CD46 downregulation and possibly immunosuppression. We will achieve these aims by dissecting the interplay between MV, CD46, and cellular factors in vitro and in cultured mouse macrophages expressing human CD46 and mutant receptors.
长期目标是了解对手和东道主

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of human complement regulatory protein CD46 restricts measles virus replication in mouse macrophages.
人类补体调节蛋白 CD46 的表达限制麻疹病毒在小鼠巨噬细胞中的复制。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY C. WONG其他文献

Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3
  • DOI:
    10.1016/j.cardfail.2023.07.003
  • 发表时间:
    2023-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    ANJALI T. OWENS;AHMAD MASRI;THEODORE P. ABRAHAM;LUBNA CHOUDHURY;FLORIAN RADER;JOHN D. SYMANSKI;ASLAN T. TURER;TIMOTHY C. WONG;ALBREE TOWER-RADER;CAROLINE J. COATS;MICHAEL A. FIFER;IACOPO OLIVOTTO;SCOTT D. SOLOMON;HUGH C. WATKINS;STEPHEN B. HEITNER;DANIEL L. JACOBY;STUART KUPFER;FADY I. MALIK;LISA MENG;REGINA SOHN
  • 通讯作者:
    REGINA SOHN

TIMOTHY C. WONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY C. WONG', 18)}}的其他基金

BRAIN RNA-MODIFYING ENZYME--CLONING AND CHARACTERIZATION
脑 RNA 修饰酶——克隆和表征
  • 批准号:
    2269350
  • 财政年份:
    1992
  • 资助金额:
    $ 17.74万
  • 项目类别:
BRAIN RNA-MODIFYING ENZYME--CLONING AND CHARACTERIZATION
脑 RNA 修饰酶——克隆和表征
  • 批准号:
    2269351
  • 财政年份:
    1992
  • 资助金额:
    $ 17.74万
  • 项目类别:
BRAIN RNA-MODIFYING ENZYME--CLONING AND CHARACTERIZATION
脑 RNA 修饰酶——克隆和表征
  • 批准号:
    3418373
  • 财政年份:
    1992
  • 资助金额:
    $ 17.74万
  • 项目类别:
BRAIN RNA-MODIFYING ENZYME--CLONING AND CHARACTERIZATION
脑 RNA 修饰酶——克隆和表征
  • 批准号:
    2269349
  • 财政年份:
    1992
  • 资助金额:
    $ 17.74万
  • 项目类别:
MEASLES VIRUS GENE FUNCTIONS BY DNA MANIPULATION
通过 DNA 操作研究麻疹病毒基因功能
  • 批准号:
    3136074
  • 财政年份:
    1986
  • 资助金额:
    $ 17.74万
  • 项目类别:
MEASLES VIRUS GENE FUNCTIONS BY DNA MANIPULATION
通过 DNA 操作研究麻疹病毒基因功能
  • 批准号:
    3136077
  • 财政年份:
    1986
  • 资助金额:
    $ 17.74万
  • 项目类别:
MEASLES VIRUS GENE FUNCTIONS BY DNA MANIPULATION
通过 DNA 操作研究麻疹病毒基因功能
  • 批准号:
    3136078
  • 财政年份:
    1986
  • 资助金额:
    $ 17.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了